Pascale Ambron

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

Arsène MEKINIAN, Artem Oganesyan, Zinaida Perić, Myriam Labopin et autres

fr, us, hr, fi, es, be, gr, sa, it, gb, tr, ru, de, Algérie (code pays fourni par la source)

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

Agnieszka Tomaszewska, Grzegorz Władysław Basak, Christophe Peczynski, Emmanuelle Polge et autres

Background: Haploidentical hematopoietic cell transplantations (haplo-HCTs) with post-transplant cyclophosphamide (PT-Cy) are standard practice, but complications causing morbidity and mortality are not well described. Methods: The aim of this prospective non-interventional multicenter study was to document frequency of potential non-infectious and infection-related complications …

pl, fr, it, tr, ch, es, fi, cz, ru, de, Algérie, gb, hr (code pays fourni par la source)

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

Agnieszka Tomaszewska, Grzegorz W. Basak, Christophe Peczynski, Emmanuelle Polge et autres

Background: Haploidentical hematopoietic cell transplantations (haplo-HCTs) with post-transplant cyclophosphamide (PT-Cy) are standard practice, but complications causing morbidity and mortality are not well described. Methods: The aim of this prospective non-interventional multicenter study was to document frequency of potential non-infectious and infection-related complications …

Improved survival in Philadelphia Chromosome–Positive acute lymphoblastic leukemia with pre-transplant second- and third-generation TKIs and post-transplant prophylactic maintenance: A study from the EBMT ALWP

Iman Abou Dalle, Jacques‐Emmanuel Galimard, Mohamed Houhou, Pascale Ambron et autres

Abstract Background: The use of tyrosine kinase inhibitors (TKIs) has improved the prognosis of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The current standard of care for fit patients involves combining TKIs with chemotherapy. Allogeneic hematopoietic cell transplantation (allo-HCT) remains …

lb, cn, Algérie, es, fr, us, ch, cz, fi, ru, be, gb, nl, Tunisie, hr, pl, it (code pays fourni par la source)

Practice Patterns of SGLT2 Inhibitor Use in Stem Cell Transplantation and CART Cell Therapy: A Study from the EBMT Transplant Complications Working Party

Christian R Schultze-Florey, Mouad Abouqateb, Christophe Peczynski, William Boreland et autres

Introduction: Sodium-glucose cotransport protein 2 inhibitors (SGLT2i) have been approved for type 2 diabetes mellitus, chronic heart failure and chronic renal insufficiency. Given treatment- and age-related occurrence of these frequent conditions, SGLT2i are increasingly used in patients with hematological malignancies. No guidelines …

de, fr, es, gb, be, ru, hr (code pays fourni par la source)

ATG and other serotherapy in conditioning regimens for autologous HSCT in autoimmune diseases: a survey on behalf of the EBMT Autoimmune Diseases Working Party (ADWP)

A. Mohamed Ismail, Rosamaria Nitti, Basil Sharrack, Manuela Badoglio et autres

Autologous hematopoietic stem cell transplantation (HSCT) is a therapeutic option for severe/refractory autoimmune diseases (AD) [ 1 , 2 ] and is now considered standard of care for highly active relapsing-remitting multiple sclerosis (MS) failing disease modifying therapies and early severe diffuse-cutaneous …

gb, it, fr, de (code pays fourni par la source)

ATG or no ATG? – survey of clinical practice in EBMT centers on behalf of the Transplant Complications Working Party of EBMT

Agnieszka Piekarska, Anna Czyż, Christophe Peczynski, Pascale Ambron et autres

pl, fr, nl, ru, be, de, hr (code pays fourni par la source)

Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT

Ivan Moiseev, Pascale Ambron, Manuela Badoglio, Christophe Peczynski et autres

ru, fr, pl, de, mm, us, be, hr (code pays fourni par la source)